Effect of perioperative dexmedetomidine on postoperative delirium in patients with brain tumours: a protocol of a randomised controlled trial
View abstract on PubMed
Summary
This summary is machine-generated.This study investigates if dexmedetomidine can reduce postoperative delirium in patients undergoing brain surgery for temporal glioma. Results will determine its effectiveness in neurosurgery patients.
Area Of Science
- Neurosurgery
- Anesthesiology
- Neuroscience
Background
- Neurosurgery poses a significant risk for developing postoperative delirium.
- Dexmedetomidine is being explored for its potential to mitigate this complication.
- Temporal glioma resections represent a specific neurosurgical context where delirium is a concern.
Purpose Of The Study
- To evaluate the efficacy of perioperative dexmedetomidine in reducing the incidence of postoperative delirium.
- To test the hypothesis that dexmedetomidine administration lowers delirium rates in patients undergoing temporal glioma surgery.
Main Methods
- A single-center, randomized, blinded, parallel-group controlled trial involving 366 patients.
- Patients were randomized into two groups: dexmedetomidine (n=183) or placebo (n=183).
- Dexmedetomidine was administered as a continuous infusion during surgery and postoperatively for 48 hours; the placebo group received normal saline.
Main Results
- The primary outcome is the incidence of postoperative delirium.
- Delirium assessment was conducted using the Confusion Assessment Method twice daily for the first five postoperative days.
- Data collection and analysis are pending to determine the primary outcome.
Conclusions
- The study is designed to provide crucial data on dexmedetomidine's role in preventing postoperative delirium after neurosurgery.
- Findings will inform clinical practice guidelines for managing delirium in patients undergoing temporal glioma resection.
- Dissemination of results is planned through scientific conferences and peer-reviewed publications.
Related Concept Videos
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...

